Skip to main content

Zepbound Dosage

Generic name: tirzepatide 2.5mg in 0.5mL
Dosage form: subcutaneous injection
Drug class: Incretin Mimetics (GLP-1 Agonists)

Medically reviewed by Drugs.com. Last updated on Nov 9, 2023.

Patient Selection

Select adult patients for ZEPBOUND treatment as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management based on their BMI. Table 1 presents a chart for determining BMI based on height and weight. BMI is calculated by dividing weight (in kilograms) by height (in meters) squared.

Table 1: BMI Conversion Chart

Table 1

Recommended Dosage

  • The recommended starting dosage of ZEPBOUND is 2.5 mg injected subcutaneously once weekly. The 2.5 mg dosage is for treatment initiation and is not intended for chronic weight management.
  • After 4 weeks, increase the dosage to 5 mg injected subcutaneously once weekly.
  • The dosage may be increased in 2.5 mg increments, after at least 4 weeks on the current dose.
  • The recommended maintenance dosages of ZEPBOUND in adults are 5 mg, 10 mg, or 15 mg injected subcutaneously once weekly.
  • Consider treatment response and tolerability when selecting the maintenance dosage. If patients do not tolerate a maintenance dosage, consider a lower maintenance dosage.
  • The maximum dosage of ZEPBOUND is 15 mg injected subcutaneously once weekly.

Recommendations Regarding Missed Dose

  • If a dose is missed, instruct patients to administer ZEPBOUND as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once weekly dosing schedule.
  • The day of weekly administration can be changed, if necessary, as long as the time between the two doses is at least 3 days (72 hours).

Important Administration Instructions

  • Prior to initiation of ZEPBOUND, train patients and caregivers on proper injection technique. Refer to the accompanying Instructions for Use for complete administration instructions with illustrations.
  • Inspect ZEPBOUND visually before use. It should appear clear and colorless to slightly yellow. Do not use ZEPBOUND if particulate matter or discoloration is seen.
  • Administer ZEPBOUND once weekly at any time of day, with or without meals.
  • Inject ZEPBOUND subcutaneously in the abdomen, thigh, or upper arm.
  • Rotate injection sites with each dose.

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.